Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avara has agreed to acquire the largest sterile manufacturing facility for injectable medicines in Canada from a global pharmaceutical company, as part of a continuing expansion of its global footprint.
read more
Don Kania, Ph.D., has been appointed to the Board of Directors of Aldevron, a global provider of plasmid DNA manufacturing, protein production and antibody discovery services.
read more
MabPlex has established their new state of the art Process Development Center of Excellence located in La Jolla, CA with scale up capacity to 200L.
read more
Ajinomoto Althea announced that Bert Barbosa and Darwin Richardson, MBA, have joined Althea as Vice President of Drug Product Manufacturing and Vice President of Compliance, respectively.
read more
Paragon Bioservices has appointed Gerard Fleury as Chief Financial Officer.
read more
Hi-Tech Pharmaceuticals has received third-party independent GMP certification of its Georgia and Pennsylvania facilities.
read more
According to the complaint, despite Delta Pharma’s repeated promises to correct deficiencies, Delta Pharma continued to violate the law.
read more
Cambrex Corporation will expand research and development capabilities at its site in Paullo, Milan, Italy.
read more
Recipharm and Sanofi announced they have signed an agreement to transfer the Holmes Chapel site from Sanofi to Recipharm.
read more
STA Pharmaceutical announced its partner, Ascletis has received approval from China Food and Drug Administration of its Category 1 new drug, Ganovo, to treat viral hepatitis C.
read more
Oncobiologics has entered into a MSA with Sonnet BioTherapeutics, a privately held development stage biopharmaceutical company, and has officially launched its BioSymphony Platform.
read more
Recipharm will acquire Sanofi’s contract inhalation drug business and plant in the U.K.
read more
TraceLink announced that IBI Lorenzini has selected TraceLink's solutions to ensure compliance with global serialization regulations.
read more
BrainStorm Cell Therapeutics has contracted with the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute as a second U.S. manufacturing site to supply NurOwn.
read more
Juniper Pharmaceuticals has entered into a definitive agreement with Catalent to acquire all of the outstanding shares of Juniper at a price of $11.50 per share in cash.
read more